Relationship Between Four Non-Insulin-Based Indexes of Insulin Resistance and Serum Uric Acid in Patients with Type 2 Diabetes: A Cross-Sectional Study

References

• Sheu W, Chan SP, Matawaran BJ, et al. Use of SGLT-2 inhibitors in patients with type 2 diabetes mellitus and abdominal obesity: an Asian perspective and expert recommendations. Diabetes Metab J. 2020;44(1):11–32. doi:10.4093/dmj.2019.0208
   PubMed Web of Science ®Google Scholar
• Shao Y, Shao H, Sawhney Monika S, et al. Serum uric acid as a risk factor of all-cause mortality and cardiovascular events among type 2 diabetes population: meta-analysis of correlational evidence. J Diabetes Complicat. 2019;33(10):107409. doi:10.1016/j.jdiacomp.2019.07.006
   PubMed Web of Science ®Google Scholar
• White J, Sofat R, Hemani G, et al. Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis. Lancet Diabetes Endocrinol. 2016;4(4):327–336. doi:10.1016/S2213-8587(15)00386-1
   PubMed Web of Science ®Google Scholar
• Mallat SG, Al Kattar S, Tanios BY, et al. Hyperuricemia, hypertension, and chronic kidney disease: an emerging association. Curr Hypertens Rep. 2016;18(10):74. doi:10.1007/s11906-016-0684-z
   PubMed Web of Science ®Google Scholar
• Li C, Hsieh MC, Chang SJ. Metabolic syndrome, diabetes, and hyperuricemia. Curr Opin Rheumatol. 2013;25(2):210–216. doi:10.1097/BOR.0b013e32835d951e
   PubMed Web of Science ®Google Scholar
• Cicero AFG, Fogacci F, Giovannini M, et al. Interaction between low-density lipoprotein- cholesterolaemia, serum uric level and incident hypertension: data from the Brisighella Heart Study. J Hypertens. 2019;37(4):728–731. doi:10.1097/HJH.0000000000001927
   PubMed Web of Science ®Google Scholar
• Cho NH, Shaw JE, Karuranga S, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–281. doi:10.1016/j.diabres.2018.02.023
   PubMed Web of Science ®Google Scholar
• Balakumar P, Maung-U K, Jagadeesh G. Prevalence and prevention of cardiovascular disease and diabetes mellitus. Pharmacol Res. 2016;113:600–609. doi:10.1016/j.phrs.2016.09.040
   PubMed Web of Science ®Google Scholar
• Bardin T, Richette P. Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options. BMC Med. 2017;15(1):123. doi:10.1186/s12916-017-0890-9
   PubMed Web of Science ®Google Scholar
• Yamada A, Sato KK, Kinuhata S, et al. Association of visceral fat and liver fat with hyperuricemia. Arthrit Care Res. 2016;68(4):553–561. doi:10.1002/acr.22729
   PubMed Web of Science ®Google Scholar
• Rudvik A, Mansson M. Evaluation of surrogate measures of insulin sensitivity-correlation with gold standard is not enough. BMC Med Res Methodol. 2018;18(1):64. doi:10.1186/s12874-018-0521-y
   Web of Science ®Google Scholar
• Borai A, Livingstone C, Kaddam I, et al. Selection of the appropriate method for the assessment of insulin resistance. BMC Med Res Methodol. 2011;11:158. doi:10.1186/1471-2288-11-158
   PubMed Web of Science ®Google Scholar
• Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299. doi:10.1089/met.2008.0034
   PubMedGoogle Scholar
• Er LK, Wu S, Chou HH, et al. Triglyceride glucose-body mass index is a simple and clinically useful surrogate marker for insulin resistance in nondiabetic individuals. PLoS One. 2016;11(3):e0149731. doi:10.1371/journal.pone.0149731
   PubMed Web of Science ®Google Scholar
• Fahim A, Gerald MR. Comparison of two methods using plasma triglyceride concentration as a surrogate estimate of insulin action in nondiabetic subjects: triglycerides × glucose versus triglyceride/high-density lipoprotein cholesterol. Metabolism. 2011;60(12):1673–1676. doi:10.1016/j.metabol.2011.04.006
   Web of Science ®Google Scholar
• Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D, et al. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol. 2018;178(5):533–544. doi:10.1530/EJE-17-0883
   PubMed Web of Science ®Google Scholar
• Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation. Diabetic Med. 1998;15(7):539–553. doi:10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   PubMed Web of Science ®Google Scholar
• Zhou JG. Chinese multi-disciplinary consensus on the diagnosis and treatment of hyperuricemia and its related diseases. Chin J Intern Med. 2017;56(3):235–248.
   Google Scholar
• Levin A, Stevens PE, Bilous RW, et al. Kidney disease: improving global outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3(1):1–150.
   Web of Science ®Google Scholar
• Wang XJ, Qian XW, Zhang X, et al. Association of serum uric acid with thyroid function in health check-up participants. Chin Med J. 2020;133(12):1409–1414. doi:10.1097/CM9.0000000000000840
   Web of Science ®Google Scholar
• Chinese association of physicians in nephrology. Guidelines for the diagnosis and treatment of renal hyperuricemia in China (2017 edition). Chin Med J. 2017;97(25):1927–1936.
   Google Scholar
• Martínez-Sánchez FD, Vargas-Abonce VP, Guerrero-Castillo AP, et al. Serum uric acid concentration is associated with insulin resistance and impaired insulin secretion in adults at risk for type 2 diabetes. Prim Care Diabetes. 2021;15(2):293–299. doi:10.1016/j.pcd.2020.10.006
   PubMed Web of Science ®Google Scholar
• Blendea MC, Jacobs D, Stump CS, et al. Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II over expression. Am J Physiol- Endocrinol Metab. 2005;288(2):353–359.
   Web of Science ®Google Scholar
• Pino AD, DeFronzo RA. Insulin resistance and atherosclerosis: implicationsfor insulin sensitizing agents. Endocr Rev. 2019;40(6):1447–1467. doi:10.1210/er.2018-00141
   Web of Science ®Google Scholar
• Bjelakovic B, Stefanutti C, Bonic D, et al. Serum uric acid and left ventricular geometry pattern in obese children. Atheroscler Supp. 2019;40:88–93. doi:10.1016/j.atherosclerosissup.2019.08.035
   Web of Science ®Google Scholar
• Taniguchi Y, Hayashi T, Tsumura K, et al. Serum uric acid level was associated with an increased risk for hypertension but not for Type 2 diabetes. J Hypertens. 2001;19(7):1209–1215. doi:10.1097/00004872-200107000-00005
   PubMed Web of Science ®Google Scholar
• Caliceti C, Calabria D, Roda A, et al. Fructose intake, serum uric acid, and cardiometabolic disorders: a critical review. Nutrients. 2017;9(4):395. doi:10.3390/nu9040395
   PubMed Web of Science ®Google Scholar
• Roncal CA, Mu W, Croker B, et al. Effect of elevated serum uric acid on cisplatin induced acute renal failure. Am J Physiol Renal Physiol. 2007;292(1):116–122. doi:10.1152/ajprenal.00160.2006
   PubMed Web of Science ®Google Scholar
• Lv Q, Meng XF, He FF, et al. High serum uric acid and increased risk of type 2 diabetes: a systemic review and metaanalysis of prospective cohort studies. PLoS One. 2013;8(2):56–60.
   Web of Science ®Google Scholar
• Zhu Y, Hu Y, Huang T, et al. High uric acid directly inhibits insulin signaling and induces insulin resistance. Biochem Bioph Res Commun. 2014;447(4):707–714. doi:10.1016/j.bbrc.2014.04.080
   PubMed Web of Science ®Google Scholar
• Jalal DI, Jablonski KL, McFann K, et al. Vascular endothelial function is not related to serum uric acid in healthy adults. Am J Hypertens. 2012;25(4):407–413. doi:10.1038/ajh.2011.237
   Web of Science ®Google Scholar
• King C, Lanaspa MA, Jensen T, et al. Uric acid as a cause of the metabolic syndrome. Contrib Nephrol. 2018;192:88–102.
   PubMed Web of Science ®Google Scholar
• Baldwin W, McRae S, Marek G, et al. Hyperurieemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes. 2011;60(4):1258–1269. doi:10.2337/db10-0916
   PubMed Web of Science ®Google Scholar
• Klisic A, Kavaric N, Ninic A. Predictive values of serum uric acid and alanine-aminotransferase for fatty liver index in Montenegrin population. J Med Biochem. 2019;38(4):407–417. doi:10.2478/jomb-2019-0001
   Web of Science ®Google Scholar
• Yuan HJ, Yang XG, Shi XY, et al. Association of serum uric acid with different levels of glucose and related factors. Chin Med J. 2011;124:1443–1448.
   PubMed Web of Science ®Google Scholar
• Sánchez-García A, Rodríguez-Gutiérrez R, Mancillas-Adame L, et al. Diagnostic accuracy of the triglyceride and glucose index for insulin resistance: a systematic review. Int J Endocrinol. 2020;2020:4678526. doi:10.1155/2020/4678526
   PubMed Web of Science ®Google Scholar
• Bittner V, Johnson BD, Zineh I, et al. The TG/HDL cholesterol ratio predicts all cause mortality in women with suspected myocardial ischemia a report from the Women’s ischemia syndrome evaluation (WISE). Am Heart J. 2009;157(3):548. doi:10.1016/j.ahj.2008.11.014
   PubMed Web of Science ®Google Scholar
• Van Linthout S, Spillmann F, Schultheiss HP, et al. High-density lipoprotein at the interface of type 2 diabetes mellitus and cardiovascular disorders. Curr Pharm Des. 2010;16(13):1504–1516. doi:10.2174/138161210791051031
   Web of Science ®Google Scholar
• Klisic A, Kavaric N, Ninic A. Serum cystatin C levels are associated with triglycerides/high-density lipoprotein cholesterol ratio in adolescent girls ages between 16–19 years old. Eur Rev Med Pharmacol Sci. 2020;24(20):10680–10686. doi:10.26355/eurrev_202010_23426
   PubMed Web of Science ®Google Scholar
• Liu XZ, Xu X, Zhu JQ, Zhao DB. Association between three non-insulin-based indexes of insulin resistance and hyperuricemia. Clin Rheumatol. 2019;38(11):3227–3233. doi:10.1007/s10067-019-04671-6
   PubMed Web of Science ®Google Scholar
• Yu X, Wang L, Zhang W, et al. The fasting triglycerides and glucose (TyG) index is more suitable for the identification of metabolically unhealthy individuals of Chinese adult population: a nationwide study. J Diabetes Investig. 2018;10:1050–1058.
   Web of Science ®Google Scholar
• Kojta I, Chacińska M, Błachnio-Zabielska A. Obesity, bioactive lipids, and adipose tissue inflammation in insulin resistance. Nutrients. 2020;12(5):1305. doi:10.3390/nu12051305
   PubMed Web of Science ®Google Scholar
• Bray GA, Smith SR, de Jonge L, et al. Effect of dietary protein content on weight gain, energy expenditure, and body composition during overeating: a randomized controlled trial. JAMA. 2012;307(1):47–55. doi:10.1001/jama.2011.1918
   PubMed Web of Science ®Google Scholar
• Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. New Engl J Med. 2014;371(12):1131–1141. doi:10.1056/NEJMra1011035
   PubMed Web of Science ®Google Scholar
• Peng TC, Wang CC, Kao TW, et al. Relationship between hyperuricemia and lipid profiles in US adults. BioMed Res Int. 2015;2015:127596. doi:10.1155/2015/127596
   Web of Science ®Google Scholar
• Matsuura F, Yamashita S, Nakamura T, et al. Effect of visceral fat accumulation on uric acid metabolism in male obese subjects: visceral fat obesity is linked more closely to overproduction of uric acid than subcutaneous fat obesity. Metabolism. 1998;47(8):929–933. doi:10.1016/S0026-0495(98)90346-8
   PubMed Web of Science ®Google Scholar